封面
市場調查報告書
商品編碼
1190736

內窺鏡後處理市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Endoscope Reprocessing Market - Growth, Trends, Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,內窺鏡後處理市場預計將以 7.8% 的複合年增長率增長。

COVID-19 對內窺鏡後處理市場產生了重大影響,原因是大流行早期嚴格的封鎖規定導致後處理設施突然關閉。 此外,大流行早期內窺鏡檢查的減少對市場增長產生了顯著影響。 然而,在大流行後採取適當措施保護內窺鏡後處理程序有望推動市場增長。 例如,2021 年 10 月發表的一篇 NCBI 論文指出,鼓勵內窺鏡後處理人員繼續使用適當的個人防護裝備,如手套、防護服和麵罩。 此類內窺鏡安全再處理指南有望在預測期內推動市場增長。

推動內窺鏡後處理市場增長的主要因素是:與內窺鏡相關的傳染病病例不斷增加,醫院對內窺鏡設備的投資增加,以及需要內窺鏡手術的疾病。 已經證實,內窺鏡儀器在疾病診斷和治療中的使用正在增加。 肺癌和慢性阻塞性肺病等呼吸系統疾病負擔的增加正在推動預測期內的市場增長。 例如,根據 2022 年 3 月發表的 NCBI 論文,估計 2021 年南亞國家慢性阻塞性肺病的合併患病率為 11.1%。 它還指出,印度北部 (19.4%) 和孟加拉國 (13.5%) 的慢性阻塞性肺病患病率最高。 如此高的慢性阻塞性肺疾病負擔有望推動內窺鏡檢查的需求,從而促進市場增長。

此外,由於內窺鏡被廣泛用於癌症診斷,癌症患者數量的增加也有望促進對內窺鏡的後處理需求,從而促進市場的增長。 例如,IARC 2021 報告稱,這些人中有 115 萬人患有結直腸癌,預計到 2040 年這一數字將達到 192 萬。 此外,2021 年 7 月發表的一篇 NCBI 論文提到,印度結直腸癌的年齡標準化發病率為每 10 萬人中男性 7.2 例,女性 5.1 例。 因此,內窺鏡主要用於診斷目的的各種類型癌症的負擔迅速增加,從長遠來看正在推動內窺鏡後處理的增長。

此外,對恢復更快、術後感染更少、疼痛更小、疤痕更少、出血控制更好、精度更高的手術的需求不斷增長,導致對各種內窺鏡器械的需求預計會增加。 市場上的主要參與者都在關注新產品的批准,以擴大他們的產品組合。 例如,2021 年 4 月,Advanced Sterilization Products 的 ASP AEROFLEX 自動內窺鏡清洗機獲得了美國食品藥品監督管理局的認可。 因此,內窺鏡清洗機市場的單位數量正在增加,預計將導致市場高速增長。

但是,執行內窺鏡手術的熟練專業人員的短缺以及對再處理器械安全性的擔憂預計會阻礙市場增長。

主要市場趨勢

自動內窺鏡洗消機部分預計在預測期內實現高速增長。

內窺鏡清洗機將可重複使用的內窺鏡的外表面和內通道暴露在高濃度消毒劑或液體化學滅菌劑中,以去除內窺鏡內部或表面的污染物。一種旨在殺死微生物的設備。 此外,建議使用自動內窺鏡清洗機的各種指南也有望促進所研究領域的增長。 例如,2021年1月,一次性內窺鏡文章指南中提到,在正常情況下,一個週期的高水平消毒,最好是自動內窺鏡清洗機,可以確保充分的清洗。列出了GI Society的更新指南。

同樣,考慮到自動內窺鏡洗消機的額外功能,預計產品發布和批准的增加將在預測期內推動研究領域。 同樣,2022 年 6 月,Getinge 推出了更新的 ED-Flow 自動內窺鏡清洗機。 ED-Flow 可有效地對柔性內窺鏡進行洩漏測試、清潔和高水平消毒,提供有效和可靠的結果。 此外,還增加了一個新的過程指示燈,即使在房間的另一端也可以輕鬆檢查過程狀態,從而改善了部門的工作流程並提高了生產率。 因此,此類創新產品的推出將提高效率並推動市場增長。

此外,2021 年 5 月,美國食品和藥物管理局 (FDA) 批准了 Advanced Sterilization 的 ASP Aeroflex,它可以自動清潔和消毒內窺鏡,並獲得 510(k) 許可。 Advanced Sterilization 的設備可以在 22 分鐘內自動清潔和消毒來自多個製造商的柔性內窺鏡,無需手動試紙測量消毒劑濃度。 因此,此類批准可能會增加細分市場的增長。

預計在預測期內北美將佔據很大的市場份額

北美佔據大部分市場份額,美國在北美地區佔據主要份額。 該地區疾病數量的增加以及主要市場參與者不斷增加的發布和收購是推動所研究市場增長的主要因素。 該地區癌症病例的增加也有望推動對內窺鏡檢查程序的需求,從而刺激市場增長。

例如,根據加拿大癌症協會的數據,2022 年將有約 24,300 名加拿大人被診斷出患有結直腸癌。 因此,結直腸癌的增加將需要更高的診斷率,這將推動對內窺鏡檢查的需求,從而提高監測市場的增長率。

此外,該地區產品發布的增加和主要參與者的高度集中預計將提振市場。 例如,2021年1月,奧林巴斯推出了帶內窺鏡收納櫃的ScopeLocker,HEPA鉸鏈門內窺鏡收納系統。 奧林巴斯感染預防產品陣容的擴大響應了胃腸道領域瞬息萬變的環境。 2021年1月,IDESCO將發佈內窺鏡乾燥存儲“IDESCO ENDO D3”。 因此,上述所有因素預計將在預測期內增加北美市場的增長。

競爭格局

由於後處理過程中使用的設備和消耗品數量眾多,該市場既有跨國公司,也有本地公司。 一些市場參與者包括 Advanced Sterilization Products(強生公司)、Cantel Medical、Custom Ultrasonics、Ecolab Inc、Endo-Technik W. Griesat、Getinge AB、Metrex Research, LLC、Olympus Corporation、STERIS plc。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病和癌症的負擔越來越重
    • 越來越喜歡微創手術
    • 增加了對醫院內窺鏡設備的投資,增加了自動化後處理內窺鏡的採用
  • 市場製約因素
    • 缺乏熟練的專業人員
    • 對再處理設備的安全性的擔憂
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:100 萬美元)

  • 按產品分類
    • 高濃度消毒液和試紙
    • 清潔劑和濕巾
    • 內窺鏡自動清洗機
    • 內窺鏡乾燥/儲存/運輸系統
    • 其他產品
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Cantel Medical
    • Custom Ultrasonics
    • Ecolab Inc
    • Endo-Technik W. Griesat
    • Getinge AB
    • Envista Holdings Corporation(Metrex Research LLC)
    • Olympus Corporation
    • Fortive Corporation(Advanced Sterilization Products)
    • STERIS plc.
    • HOYA Corporation
    • Steelco S.p.A.
    • BES Rehab Ltd
    • ARC Group of Companies Inc
    • Shinva Medical Instrument Co. Ltd.

第7章 市場機會今後動向

簡介目錄
Product Code: 66828

The endoscope reprocessing market is poised to grow at a CAGR of 7.8% during the forecasted period.

COVID-19 had significantly affected the endoscope reprocessing market owing to the abrupt shutdown of reprocessing facilities in the initial days of the pandemic due to the strict lockdown regulations. Also, the reductions in endoscopy procedures during the initial stages of the pandemic had a notable impact on the growth of the market. However, the adoption of the appropriate measure to follow the endoscope reprocessing procedures during the post-pandemic period is expected to drive the growth of the market. For instance, the NCBI article published in October 2021, mentioned that endoscope reprocessing staff should continue to adopt appropriate personal protective equipment including gloves, gowns, face shields, and other equipment are recommended. Such guidelines for the safe reprocessing of endoscopes are expected to drive the growth of the market over the forecast period.

The major factors driving the growth of the endoscope reprocessing market include the rising cases of endoscopy-related infections, growing hospital investments in endoscopy instruments, and the rising number of diseases that require endoscopy procedures. Increased usage of endoscopic devices has been observed in disease diagnosis and treatment. The growing burden of respiratory diseases, such as lung cancer, and chronic obstructive pulmonary disorders is propelling the market's growth over the forecast period. For instance, according to the NCBI article published in March 2022, the estimated pooled prevalence of COPD was 11.1% in South Asian countries in 2021. The report also mentioned that the prevalence of COPD was highest in North India (19.4%) and Bangladesh (13.5%). Such a high burden of Chronic Obstructive Pulmonary Disease is expected to drive the demand for endoscopy procedures, thereby contributing to the growth of the market.

Additionally, the rising number of cancer cases is also expected to contribute to the demand for endoscopy reprocessing as endoscopy procedures are widely used in diagnosing cancer, thereby contributing to the market's growth. For instance, IARC 2021 reported that out of these cases, 1.15 million cases are of colon cancer, which is expected to reach 1.92 million by 2040. Also, the NCBI article published in July 2021, mentioned that the age-standardized incidence rates of colorectal cancer in India were 7.2 and 5.1 per 100,000 population for men and women. Such a rapidly rising burden of different types of cancers, in which endoscopes are largely used for diagnostic purposes, is boosting the growth of endoscope reprocessing over time.

Furthermore, rising demand for surgeries with faster recovery, fewer post-surgery infections, less pain, reduced scarring, better control of bleeding, and increased accuracy are anticipated to boost the demand for various endoscopy devices. Major players in the market are focusing on the approval of new products to expand their product portfolio. For instance, in April 2021, Advanced Sterilization Products received United States Food and Drug Administration's support for the ASP AEROFLEX Automatic Endoscope Reprocessor. Thus, the rising number of endoscopy reprocessing devices in the market will likely lead to high growth of the market.

However, the dearth of skilled professionals to carry out endoscopic procedures and the concerns regarding the safety of reprocessed instruments are the factors expected to hinder the market growth.

Key Market Trends

Automated Endoscope Reprocessors Segment is Expected to Register Good Growth Over the Forecast Period

Automated endoscope reprocessors are designed to kill microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to high-level disinfectant or liquid chemical sterilant solutions. Also, the suggested usage of automated endoscope reprocessors in various guidelines is expected to contribute to the growth of the studied segment. For instance, in January 2021, the Single Use Endoscopy article guidelines enlisted the GI societies' updated guidelines which mentioned that under normal circumstances, one cycle of high-level disinfection, preferably in an automated endoscope reprocessor is enough to ensure adequate reprocessing.

Likewise, the increasing product launches and approvals, given the added features of automated endoscope reprocessors, are expected to drive the studied segment over the forecast period. Similarly, in June 2022, Getinge launched an updated version of the ED-Flow automated endoscope reprocessors. ED-Flow efficiently performs leak testing, cleaning, and high-level disinfection of flexible endoscopes, delivering effective, reliable results. New process indicator lights have been added to allow easy visibility of the process status from across the room, which creates improved department workflow leading to higher productivity. Hence, such innovative product launches would improve efficiency and will fuel market growth.

Additionally, in May 2021, United States Food and Drug Administration (FDA) granted 510(k) clearance for Advanced Sterilization's ASP Aeroflex, a device that automatically cleans and sterilizes endoscopes. The Advanced Sterilization device can automatically clean and disinfect flexible endoscopes from multiple manufacturers in 22 minutes, eliminating the need to use manual test strips to measure the disinfectant's concentration. Hence, such approvals are likely to increase segment growth.

North America is Expected to Hold Significant Market Share Over the Forecast Period

North America holds the majority of the share and in the North American region, United States holds the major share. The rising number of disorders and the increasing launches and acquisitions by key market players in the region are the major drivers for the growth of the studied market. Increasing cases of cancer in this region are also expected to drive the demand for endoscopy procedures, thereby fueling the growth of the market.

For instance, according to the Canadian cancer society data 2022, nearly 24,300 Canadians will be diagnosed with colorectal cancer in 2022. Thus, increasing colorectal cancer would require a higher diagnostic rate, which will fuel the demand for endoscopy and hence will increase the growth rate of the studied market.

Additionally, the increasing number of product launches and high concentration of major players in the region is expected to boost the market. For instance, in January 2021, Olympus launched the endoscope storage cabinet, the ScopeLocker with HEPA-hinged door endoscope storage system. This line expansion of Olympus' infection prevention offering addresses a rapidly shifting environment in the gastrointestinal field. Also, in January 2021, IDESCO launched the endoscope drying storage cabinet called the IDESCO ENDO D3. Hence, all the above-mentioned factors are expected to augment the growth of the North American market over the forecast period.

Competitive Landscape

The market studied involves both multinational and local companies owing to a large number of devices and consumables being used in the reprocessing process. Some of the market players are Advanced Sterilization Products (Johnson & Johnson Company), Cantel Medical, Custom Ultrasonics, Ecolab Inc, Endo-Technik W. Griesat, Getinge AB, Metrex Research, LLC., Olympus Corporation, STERIS plc., and Wassenburg Medical (A Member of Hoya).

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Disorders and Cancer
    • 4.2.2 Growing Preference for Minimally Invasive Surgeries
    • 4.2.3 Growing Hospital Investments in Endoscopy Instruments, Coupled With Rising Adoption of Automated Reprocessed Endoscope
  • 4.3 Market Restraints
    • 4.3.1 Dearth of Skilled Professional
    • 4.3.2 Concerns Regarding the Safety of Reprocessed Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 High-Level Disinfectants and Test Strips
    • 5.1.2 Detergents and Wipes
    • 5.1.3 Automated Endoscope Reprocessors
    • 5.1.4 Endoscope Drying, Storage, and Transport Systems
    • 5.1.5 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgery Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cantel Medical
    • 6.1.2 Custom Ultrasonics
    • 6.1.3 Ecolab Inc
    • 6.1.4 Endo-Technik W. Griesat
    • 6.1.5 Getinge AB
    • 6.1.6 Envista Holdings Corporation (Metrex Research LLC)
    • 6.1.7 Olympus Corporation
    • 6.1.8 Fortive Corporation (Advanced Sterilization Products)
    • 6.1.9 STERIS plc.
    • 6.1.10 HOYA Corporation
    • 6.1.11 Steelco S.p.A.
    • 6.1.12 BES Rehab Ltd
    • 6.1.13 ARC Group of Companies Inc
    • 6.1.14 Shinva Medical Instrument Co. Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS